The Engagement Use Cases for AI

A wide array of AI tools are here now or coming that will help pharma sharpen its engagement approach across medical affairs and commercial.

Patients and Medical

Improving Pain Management and Mental Health in the Hemophilia Community: Let's Take Action

At the second Hemophilia Changemakers Event of this year, in partnership with Sanofi, advocates for people living with bleeding disorders...

Patients and Medical

In today's rapidly evolving healthcare landscape, pharmaceutical companies are increasingly recognizing the transformative potential of...

Commercial
Global versus local: Mind the content gap

Anonymous (not verified), (Dec 4, 2023)

In the race to provide timely, tailored content for HCPs, pharma is rethinking its approach to how global and local content functions interact
Commercial
The partnership powering omnichannel

Joseph Constance, (Dec 4, 2023)

Mastering omnichannel requires a close working relationship between marcomms and IT
Patients and Medical
AI: The Key to Revolutionizing Medical Affairs?

Maria Aguirre G..., (Dec 4, 2023)

The integration of AI in medical affairs signifies a transformative shift, enhancing efficiency in workflows, fostering personalized patient care, and necessitating a delicate balance between innovation and regulation
Patients and Medical
Achieve global scale for your digital health solutions

Maria Aguirre G..., (Nov 28, 2023)

Pharma companies are increasingly recognizing the potential of digital health solutions to transform the healthcare landscape, and many are looking to scale their digital initiatives globally.
Commercial
Centralize data and insights to avoid decision-making delays

Maria Aguirre G..., (Nov 24, 2023)

To help boost patient-centricity, centralization of internal and external data allows for faster insight generation among pharmaceutical company teams.

Jill Donahue, (Mar 16, 2023)

For Zena Sfeir, Aitia VP Marketing, a strong sense of purpose is key to making an impact and improving lives

Jill Donahue, (Sep 5, 2022)

For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.

More Columns

Global versus local: Mind the content gap

Anonymous (not verified), (Dec 4, 2023)

In the race to provide timely, tailored content for HCPs, pharma is rethinking its approach to how global and local content functions interact
The partnership powering omnichannel

Joseph Constance, (Dec 4, 2023)

Mastering omnichannel requires a close working relationship between marcomms and IT
Centralize data and insights to avoid decision-making delays

Maria Aguirre G..., (Nov 24, 2023)

To help boost patient-centricity, centralization of internal and external data allows for faster insight generation among pharmaceutical company teams.
The Engagement Use Cases for AI

Andrew Stone, (Nov 22, 2023)

A wide array of AI tools are here now or coming that will help pharma sharpen its engagement approach across medical affairs and commercial.
Your 24-month blueprint for market launch success

Maria Aguirre G..., (Oct 27, 2023)

Pharmaceutical companies should have a market launch strategy at least two years before data from a registrational clinical trial is available.

More Commercial

Tackle social determinants of health via data and community engagement

Maria Aguirre G..., (Nov 3, 2023)

Social determinants of health can blur the safety and efficacy profiles of therapies, making it critical for the pharmaceutical industry to find ways to ease healthcare barriers.
Transform patient-driven healthcare: Synthesize RWE and AI

Maria Aguirre G..., (Sep 7, 2023)

The future of healthcare is here, and it's powered by real-world evidence (RWE) and artificial intelligence (AI), transforming patient care and clinical decision-making.
How to develop out-of-the-box evidence collection strategies to boost approval rates

Maria Aguirre G..., (Aug 18, 2023)

Enhanced evidence collection methodologies can improve approval rates and ensure reimbursement. Pharma companies should build an internal, cross-functional evidence team responsible for investigating new ways to collect and report clinical trial data
RWE’s new dataset: Social media

Andrew Stone, (Nov 22, 2022)

Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
How automation is changing regulatory affairs

Andrew Stone, (Apr 14, 2022)

Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing

More Market Access

The complexities of designing a digital business model for seamless CGT commercialization

Joseph Constance, (Dec 4, 2023)

In navigating the era of cell and gene therapy, pharmaceutical firms must strategically engage stakeholders digitally while preserving space for personalized patient care amidst the digital landscape.
AI: The Key to Revolutionizing Medical Affairs?

Maria Aguirre G..., (Dec 4, 2023)

The integration of AI in medical affairs signifies a transformative shift, enhancing efficiency in workflows, fostering personalized patient care, and necessitating a delicate balance between innovation and regulation
Achieve global scale for your digital health solutions

Maria Aguirre G..., (Nov 28, 2023)

Pharma companies are increasingly recognizing the potential of digital health solutions to transform the healthcare landscape, and many are looking to scale their digital initiatives globally.
Improving Pain Management and Mental Health in the Hemophilia Community: Let's Take Action

Maria Aguirre G..., (Oct 25, 2023)

Advocates at the Hemophilia Changemakers Event emphasize holistic well-being for individuals with bleeding disorders, calling for improved pain management and mental health support
Artificial Intelligence in Practice – How Medical Affairs Can Leverage AI Today

Maria Aguirre G..., (Oct 24, 2023)

AI is transforming Medical Affairs by analyzing data and generating insights. We gathered experts to discuss its applications in the field.

More Patients and Medical